218 related articles for article (PubMed ID: 34414413)
1. Status of biomarkers for the identification of stable or vulnerable plaques in atherosclerosis.
Lubrano V; Balzan S
Clin Sci (Lond); 2021 Aug; 135(16):1981-1997. PubMed ID: 34414413
[TBL] [Abstract][Full Text] [Related]
2. Exploring the role of extracellular matrix proteins to develop biomarkers of plaque vulnerability and outcome.
Holm Nielsen S; Jonasson L; Kalogeropoulos K; Karsdal MA; Reese-Petersen AL; Auf dem Keller U; Genovese F; Nilsson J; Goncalves I
J Intern Med; 2020 May; 287(5):493-513. PubMed ID: 32012358
[TBL] [Abstract][Full Text] [Related]
3. Biomarkers of plaque instability.
Shah PK
Curr Cardiol Rep; 2014 Dec; 16(12):547. PubMed ID: 25326730
[TBL] [Abstract][Full Text] [Related]
4. Thrombosis formation on atherosclerotic lesions and plaque rupture.
Badimon L; Vilahur G
J Intern Med; 2014 Dec; 276(6):618-32. PubMed ID: 25156650
[TBL] [Abstract][Full Text] [Related]
5. Search for Reliable Circulating Biomarkers to Predict Carotid Plaque Vulnerability.
Puig N; Jiménez-Xarrié E; Camps-Renom P; Benitez S
Int J Mol Sci; 2020 Nov; 21(21):. PubMed ID: 33153204
[TBL] [Abstract][Full Text] [Related]
6. Extreme Levels of Air Pollution Associated With Changes in Biomarkers of Atherosclerotic Plaque Vulnerability and Thrombogenicity in Healthy Adults.
Xu H; Wang T; Liu S; Brook RD; Feng B; Zhao Q; Song X; Yi T; Chen J; Zhang Y; Wang Y; Zheng L; Rajagopalan S; Li J; Huang W
Circ Res; 2019 Mar; 124(5):e30-e43. PubMed ID: 30661461
[TBL] [Abstract][Full Text] [Related]
7. Matrix vesicles in the fibrous cap of atherosclerotic plaque: possible contribution to plaque rupture.
Bobryshev YV; Killingsworth MC; Lord RS; Grabs AJ
J Cell Mol Med; 2008 Oct; 12(5B):2073-82. PubMed ID: 18194456
[TBL] [Abstract][Full Text] [Related]
8. Detecting the vulnerable plaque in patients.
Gonçalves I; den Ruijter H; Nahrendorf M; Pasterkamp G
J Intern Med; 2015 Nov; 278(5):520-30. PubMed ID: 26306911
[TBL] [Abstract][Full Text] [Related]
9. Carotid plaque vulnerability: a positive feedback between hemodynamic and biochemical mechanisms.
Cicha I; Wörner A; Urschel K; Beronov K; Goppelt-Struebe M; Verhoeven E; Daniel WG; Garlichs CD
Stroke; 2011 Dec; 42(12):3502-10. PubMed ID: 21998063
[TBL] [Abstract][Full Text] [Related]
10. Identifying Vulnerable Atherosclerotic Plaque in Rabbits Using DMSA-USPIO Enhanced Magnetic Resonance Imaging to Investigate the Effect of Atorvastatin.
Qi C; Deng L; Li D; Wu W; Gong L; Li Y; Zhang Q; Zhang T; Zhang C; Zhang Y
PLoS One; 2015; 10(5):e0125677. PubMed ID: 25973795
[TBL] [Abstract][Full Text] [Related]
11. Macrophage-mediated proteolytic remodeling of the extracellular matrix in atherosclerosis results in neoepitopes: a potential new class of biochemical markers.
Skjøt-Arkil H; Barascuk N; Register T; Karsdal MA
Assay Drug Dev Technol; 2010 Oct; 8(5):542-52. PubMed ID: 20662734
[TBL] [Abstract][Full Text] [Related]
12. Matrix Metalloproteinases as Biomarkers of Atherosclerotic Plaque Instability.
Olejarz W; Łacheta D; Kubiak-Tomaszewska G
Int J Mol Sci; 2020 May; 21(11):. PubMed ID: 32486345
[TBL] [Abstract][Full Text] [Related]
13. Gene expression levels of matrix metalloproteinases in human atherosclerotic plaques and evaluation of radiolabeled inhibitors as imaging agents for plaque vulnerability.
Müller A; Krämer SD; Meletta R; Beck K; Selivanova SV; Rancic Z; Kaufmann PA; Vos B; Meding J; Stellfeld T; Heinrich TK; Bauser M; Hütter J; Dinkelborg LM; Schibli R; Ametamey SM
Nucl Med Biol; 2014 Aug; 41(7):562-9. PubMed ID: 24853402
[TBL] [Abstract][Full Text] [Related]
14. Imaging atherosclerosis and risk of plaque rupture.
Osborn EA; Jaffer FA
Curr Atheroscler Rep; 2013 Oct; 15(10):359. PubMed ID: 23982263
[TBL] [Abstract][Full Text] [Related]
15. Assessment of RANTES levels as the indicators of plaque vulnerability in rabbit models of atherosclerosis.
Lv YB; Jing J; Li JM; Zhong JP; Fang L; Yang B
Pathol Res Pract; 2014 Dec; 210(12):1031-7. PubMed ID: 25155378
[TBL] [Abstract][Full Text] [Related]
16. [The progress of nuclear medicine and magnetic resonance molecular imaging of atherosclerotic vulnerable plaques].
Zhao ZM; Qin SC
Sheng Li Ke Xue Jin Zhan; 2011 Apr; 42(2):86-90. PubMed ID: 21770253
[TBL] [Abstract][Full Text] [Related]
17. Current Advances in the Diagnostic Imaging of Atherosclerosis: Insights into the Pathophysiology of Vulnerable Plaque.
Mushenkova NV; Summerhill VI; Zhang D; Romanenko EB; Grechko AV; Orekhov AN
Int J Mol Sci; 2020 Apr; 21(8):. PubMed ID: 32340284
[TBL] [Abstract][Full Text] [Related]
18. Pathophysiology of atherosclerosis plaque progression.
Sakakura K; Nakano M; Otsuka F; Ladich E; Kolodgie FD; Virmani R
Heart Lung Circ; 2013 Jun; 22(6):399-411. PubMed ID: 23541627
[TBL] [Abstract][Full Text] [Related]
19. Molecular imaging of matrix metalloproteinases in atherosclerotic plaques.
Lenglet S; Thomas A; Chaurand P; Galan K; Mach F; Montecucco F
Thromb Haemost; 2012 Mar; 107(3):409-16. PubMed ID: 22274652
[TBL] [Abstract][Full Text] [Related]
20. Plaque Rupture and Thrombosis: the Value of the Atherosclerotic Rabbit Model in Defining the Mechanism.
Abela OG; Ahsan CH; Alreefi F; Salehi N; Baig I; Janoudi A; Abela GS
Curr Atheroscler Rep; 2016 Jun; 18(6):29. PubMed ID: 27091328
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
